{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-042948","form_type":"8-K","ticker":"AQST","cik":"0001398733","company_name":"Aquestive Therapeutics, Inc.","filed_at":"2024-10-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.341972+00:00","generated_at":"2026-05-30T13:39:32.850749+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"high","headline":"Aquestive amends bylaws: shortens nomination look-back to 2 years, updates terminology","bullets":["Stockholder nomination look-back period shortened from three years to two years.","All references to 'chairman' replaced with 'chair' for modernization.","Amendments approved by Board and effective immediately on October 16, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-042948","json":"https://secwatch.observer/filing/0001628280-24-042948.json","markdown":"https://secwatch.observer/filing/0001628280-24-042948.md","text":"https://secwatch.observer/filing/0001628280-24-042948.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1398733/000162828024042948/0001628280-24-042948-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1398733/000162828024042948/aqst-20241016.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T13:39:32.850749+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}